Adjuvant Holdings Co.,Ltd.
Tokyo Stock ExchangeTotal Valuation
Adjuvant Holdings Co.,Ltd. carries a market capitalization of 5.87B, placing it among publicly traded companies globally. Its enterprise value stands at 4.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.87B |
| Enterprise Value | 4.53B |
Share Statistics
Adjuvant Holdings Co.,Ltd. currently has 8.02M shares outstanding.
| Shares Outstanding | 8.02M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Adjuvant Holdings Co.,Ltd. trades at a trailing price-to-earnings ratio of 111.20. The price-to-sales ratio is 1.53, and the price-to-book ratio stands at 1.92.
| PE Ratio | 111.20 |
| PS Ratio | 1.53 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 1.05 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.05 |
| EV / EBITDA | 30.89 |
| EV / EBIT | 30.89 |
| EV / FCF | N/A |
Financial Position
Adjuvant Holdings Co.,Ltd. maintains a current ratio of 5.71, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.71 |
| Quick Ratio | 3.37 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Adjuvant Holdings Co.,Ltd. posts a return on equity of 1.72 and a return on invested capital of 1.21.
| Return on Equity (ROE) | 1.72 |
| Return on Assets (ROA) | 1.13 |
| Return on Invested Capital (ROIC) | 1.21 |
| Return on Capital Employed (ROCE) | 1.72 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.50 |
Taxes
Over the trailing twelve months, Adjuvant Holdings Co.,Ltd. has paid 110.70M in income taxes, reflecting an effective tax rate of 65.18.
| Income Tax | 110.70M |
| Effective Tax Rate | 65.18 |
Stock Price Statistics
Adjuvant Holdings Co.,Ltd.'s stock has declined approximately -14.75029% over the past 52 weeks. The 50-day moving average sits at 733.48, while the 200-day moving average is 763.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.75029% |
| 50-Day Moving Average | 733.48 |
| 200-Day Moving Average | 763.70 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Adjuvant Holdings Co.,Ltd. generated 4.30B in revenue and converted that into 59.14M in net income, yielding earnings per share of 7.39. EBITDA reached 146.58M, while operating income came in at 146.58M.
| Revenue | 4.30B |
| Gross Profit | 2.77B |
| Operating Income | 146.58M |
| Pretax Income | 169.84M |
| Net Income | 59.14M |
| EBITDA | 146.58M |
| EBIT | 146.58M |
| Earnings Per Share (EPS) | 7.39 |
Balance Sheet
Total book value stands at 3.42B, with working capital of 2.86B providing operational flexibility.
| Cash & Cash Equivalents | 2.05B |
| Total Debt | N/A |
| Net Debt | -2.05B |
| Equity (Book Value) | 3.42B |
| Book Value Per Share | 427.39 |
| Working Capital | 2.86B |
Margins
Adjuvant Holdings Co.,Ltd. operates with a gross margin of 64.31, reflecting its pricing power and cost economics. The operating margin of 3.41 and net profit margin of 1.37 provide insight into operational efficiency.
| Gross Margin | 64.31 |
| Operating Margin | 3.41 |
| Pretax Margin | 3.95 |
| Profit Margin | 1.37 |
| EBITDA Margin | 3.41 |
Stock Splits
Adjuvant Holdings Co.,Ltd.'s most recent stock split took place on August 16, 2013 with a 1:2 split ratio.
| Last Split Date | 8/16/2013 |
| Split Ratio | 1:2 |
Scores
Adjuvant Holdings Co.,Ltd. posts an Altman Z-Score of 6.01, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.01 |